Fact check
“As of March 2025 the FDA still faced a massive backlog of about 130,000 pre‑market applications.”
Reasoning
The claim is corroborated by a secondary reporting article from Reason.com, which quotes the lawsuit’s figures for the FDA backlog in March 2025. No contradictory evidence is presented.
On confidence: The provided source directly states that as of last March (2025) the FDA faced a massive backlog of about 130,000 pre‑market applications.
Important context
The backlog figure is cited in the context of a lawsuit challenging the FDA's nicotine product regulations and refers specifically to pre‑market applications for nicotine products.
Evidence
Supporting (1)
- Tier 3 — Secondary reportingThe FDA promises to streamline the dauntingly complex rules for approving nicotine products
"have been difficult for both stakeholders and [the FDA] to apply in practice." As of last March, according to the lawsuit, the FDA "still faced a massive backlog" of about 130,000 premarket applications. In September 2025, the FDA…
Limitations
The evidence is a secondary report and relies on information from a lawsuit; no primary FDA data is provided. However, the article directly quotes the stated backlog figure. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:41 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
The FDA Promises To Streamline the Dauntingly Complex Rules for Approving Nicotine ProductsReason · Jacob Sullum